Activity of potassium channel-blockers in breast cancer

Anticancer Research

Volumn 23, Issue 4, 2003, Pages 3347-3351

  Abdul, Mansoor ^a   Santo, Arben ^a   Hoosein, Naseema ^a,b  

^a EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b EVVCOM   (United States)

Author keywords

Amiodarone; Breast; Colon; Dequalinium; Potassium channel; Prostate; Tamoxifen

Indexed keywords

AMIODARONE; DEQUALINIUM; MINOXIDIL; POTASSIUM CHANNEL BLOCKING AGENT; TAMOXIFEN; VOLTAGE GATED POTASSIUM CHANNEL;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; EPITHELIUM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; PROSTATE CANCER;

AMIODARONE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELL DIVISION; DEQUALINIUM; DRUG SYNERGISM; GLYBURIDE; HUMANS; IMMUNOHISTOCHEMISTRY; MINOXIDIL; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0042530130     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. McCormack T, McCormack K, Nadal MS, Vieira E, Ozaita A and Rudy B: The effects of Shaker beta-subunits on the human lymphocyte K+ channel Kvl.3. J Biol Chem 274: 20123-20126, 1999.
2. Xu D, Wang L, Dai W and Lu L: A requirement for K+-channel activity in growth factor-mediated extracellular signal-regulated kinase activation in human myeloblastic leukemia ML-1 cells. Blood 94: 139-145, 1999.
3. Artym VV and Petty HR: Molecular proximity of Kv1.3 voltage-gated potassium channels and betal-integrins on the plasma membrane of melanoma cells:effects of cell adherence and channel blockers. J Gen Physiol 120: 29-37, 2002.
4. Yao X and Kwan HY: Activity of voltage-gated K+ channels is associated with cell proliferation and calcium influx in carcinoma cells of colon cancer. Life Sci 65: 55-62, 1999.
5. Aldous WK, Marean AJ, DeHart MJ, Matej LA and Moore KH: Effects of tamoxifen on telomerase activity in breast carcinoma cell lines. Cancer 85: 1523-1529, 1999.
6. Abdul M and Hoosein NM: Relationship of IL-1 system with neuroendocrine and exocrine differentiation in human colon cancer cell lines. Cytokine 18: 86-91, 2002.
7. Strobl JS, Wonderlin WF and Flynn DC: Mitogenic signal transduction in human breast cancer cells. Gen Pharmacol 26: 1643-1649, 1995.
8. Wegman EA, Young JA and Cook DI: A 23-pS calcium activated potassium channel in MCF-7 human breast carcinoma cells: an apparent correlation of channel incidence with the rate of cellular proliferation. Pflugers Arch 417: 562-570, 1991.
9. Gallagher JD, Fay MJ, North WG and McCann FV: Ionic signals in T.47D human breast cancer specimens. Cell Signal 8: 279-284, 1996.
10. Abdul M and Hoosein NM: Expression and activity of potassium ion channels in human prostate cancer. Cancer Letters 186: 99-106, 2002.
11. Abdul M and Hoosein NM: Voltage-gated potassium ion channels in colon cancer. Oncology Rep 9: 961-964, 2002.
12. Kim IY, Seong H, Kim BC, Lee DK, Remaley AT, Leach F, Morton RA and Kim SJ: Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway. Cancer Res 62: 3649-3653, 2002.
13. Arai N, Strom A, Rafter JJ and Gustafsson JA: Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein. Biochem Biophys Res Commun 270: 425-431, 2000.